The Different Strategies for the Radiolabeling of [<sup>211</sup>At]-Astatinated Radiopharmaceuticals

The Different Strategies for the Radiolabeling of [<sup>211</sup>At]-Astatinated Radiopharmaceuticals

Astatine-211 (<sup>211</sup>At) has emerged as a promising radionuclide for targeted alpha therapy of cancer by virtue of its favorable nuclear properties. However, the limited in vivo stability of <sup>211</sup>At-labeled radiopharmaceuticals remains a major challenge. This...

Full description

Bibliographic Details
Main Authors: Jie Gao, Mei Li, Jingjing Yin, Mengya Liu, Hongliang Wang, Jin Du, Jianguo Li
Format: Article
Language:English
Published: MDPI AG 2024-05-01
Series:Pharmaceutics
Subjects:
astatine
radiolabeling
radiopharmaceuticals
targeted alpha therapy
Online Access:https://www.mdpi.com/1999-4923/16/6/738

Internet

https://www.mdpi.com/1999-4923/16/6/738

Similar Items